The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Levafluke Oral Drench

15,22.5 milligram(s)/millilitre Oral suspension

Biochem LtdVPA10926/008/001

Main Information

Trade NameLevafluke Oral Drench
Active SubstancesLevamisole hydrochloride
Strength15,22.5 milligram(s)/millilitre
Dosage FormOral suspension
Licence HolderBiochem Ltd
Licence NumberVPA10926/008/001

Group Information

ATC CodeQP52AE51 levamisole, combinations
Therapeutic ClassEndoparasiticide


Licence Issued01/10/1999
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back